Cerebral Diagnostics Canada Inc. Announces That the US Patent and Trademark Office Has Issued a Patent for DECI, a New Live 3D Real-Time Brain Imaging "Camera"
Dynamic Electrical Cortical Imaging (DECI) is a safe, non-invasive, affordable and portable alternative to existing imaging tools such as fMRI, MRI and PET. Unlike, the existing technologies, DECI captures and localizes the electrical activity of the cerebral cortex as it is occurring in real-time and displays it in the form of 3D motion pictures.
TORONTO, CANADA, November 10, 2015 (Newswire.com) - Cerebral Diagnostics Canada Inc., a Toronto start-up company is proud to announce that the US Patent and Trademark Office has issued patent no. 9,179,854 for its brain imaging technology, DECI.
HOW DECI WORKS: DECI captures and displays the three-dimensional electrical activity of the brain in real-time using conventional off-the-shelf electroencephalographic (EEG) equipment. Like an EEG, this technology is inherently safe and non-invasive, merely requiring the contact of electrodes to a person's scalp. However, unlike conventional EEG, whose waves are pale reflections of the underlying complexities within the brain, DECI, through the use of a high-level mathematical transformation known as an inverse solution, produces vivid representations of moving electrical fields. The output of the software includes a stream of images on a screen. Using colour and lines DECI depicts the locations of the generators of the wave-forms seen on an EEG.
DECI is an advance on an emerging technology called source-localization. Prior to DECI others created the technology to make still images showing the locations of the electrical activities of the cerebral cortex. Our innovation was to make a stream of these still images live and in realtime. DECI has many potential applications including: as a guidance system for medical treatments, as a tool for biofeedback to train the brain, as a monitoring system for sleep, as a tool for brain computer interfacing for gaming and as a tool for medical and psychological research.
Dr. Mark Doidge, President
BACKGROUND: The human cerebral cortex is the convoluted outer surface of the brain, commonly known as 'the gray matter'. It is responsible for many of the higher functions of the mind including those associated with thought, action, emotion and sensation. The cerebral cortex, largely due to its complexity, is also susceptible to a large number of disorders and diseases. Many of these diseases lack proper objective diagnostic tests or currently require expensive medical equipment to diagnose them.
Often, in order to diagnose diseases of the brain 3D localization and imaging is required. There are a number of existing technologies that have been utilized that accomplish this including Functional Magnetic Resonance Imaging (fMRI). Each of the existing technologies has its strengths and weaknesses.
5 Simple Advantages of DECI over existing technologies:
- DECI can localize the rapid changes in electrical activity in the human cerebral cortex in three-dimensions in real-time. Thus, with further development and real-time analysis the invention could be used to make an instant diagnosis.
- DECI is very inexpensive when compared to other imaging technologies such as fMRI, CT, MEG and PET.
- DECI is safe and non-invasive.
- DECI is portable. With additional funding, this portability can be further improved, and the entire system can be wireless. This will create a new frontier for psychology and medicine because it will allow for the use of brain imaging to study psychological functions in real life. Presently, brain imaging is only conducted in the stilted environment of laboratories where many important spontaneous emotions and mental processes do not occur.
- DECI can acquire over 2000 images per second. This enables it to capture numerous fine events that are blurred together as one with most competing technologies.
For more information or to schedule an interview please contact Cerebral Diagnostics Canada Inc: (647) 352-5232 or info@cerebraldiagnostics.com.
Direct Link to Patent on USPTO website : http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9179854.PN.&OS=PN/9179854&RS=PN/9179854
Link to Cerebral Diagnostics Canada Inc. website: www.cerebraldiagnostics.com
Investor inquiries and licensing inquiries welcome.
The content of this press release including the associated still images, text and movies are made available under a Creative Commons Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) license.